Daniël H. van Raalte
机构：Amsterdam UMC Location University of Amsterdam, Amsterdam Neuroscience, Amsterdam University Medical Centers, Amsterdam Cardiovascular Sciences, Amsterdam University of Applied Sciences, Vrije Universiteit Amsterdam, University of Amsterdam, Amsterdam UMC Location Vrije Universiteit Amsterdam · ORCID：0000-0003-2894-6124
发表论文 374 篇 · 总被引 13717 次 · h-index 57
代表论文
- Effectiveness and safety of combining SGLT2 inhibitors and GLP-1 receptor agonists in individuals with type 2 diabetes: a systematic review and meta-analysis of cohort studies (2025 · Diabetologia · 被引 21)
- GLP-1 agonists in the treatment of chronic kidney disease in type 2 diabetes and obesity (2025 · Journal of Clinical Investigation · 被引 19)
- Kidney Parameters with Tirzepatide in Obesity with or without Type 2 Diabetes (2025 · Journal of the American Society of Nephrology · 被引 18)
- Effects of Semaglutide With or Without Concomitant Mineralocorticoid Receptor Antagonist Use in Participants With Type 2 Diabetes and Chronic Kidney Disease: A FLOW Trial Prespecified Secondary Analysis (2025 · Diabetes Care · 被引 17)
- Tirzepatide Treatment and Associated Changes in β-Cell Function and Insulin Sensitivity in People With Obesity or Overweight With Prediabetes or Normoglycemia: A Post Hoc Analysis From the SURMOUNT-1 Trial (2025 · Diabetes Care · 被引 15)
- Oral Semaglutide and Heart Failure Outcomes in Persons With Type 2 Diabetes (2026 · JAMA Internal Medicine · 被引 12)